ATE360097T1 - Spezifisch vom genom von mycobacterium tuberculosis deletierte sequenzen und deren verwendung in der diagnostik und als vakzine - Google Patents

Spezifisch vom genom von mycobacterium tuberculosis deletierte sequenzen und deren verwendung in der diagnostik und als vakzine

Info

Publication number
ATE360097T1
ATE360097T1 AT02290458T AT02290458T ATE360097T1 AT E360097 T1 ATE360097 T1 AT E360097T1 AT 02290458 T AT02290458 T AT 02290458T AT 02290458 T AT02290458 T AT 02290458T AT E360097 T1 ATE360097 T1 AT E360097T1
Authority
AT
Austria
Prior art keywords
mycobacterium
vaccines
diagnostics
mycobacterium tuberculosis
sequences specifically
Prior art date
Application number
AT02290458T
Other languages
English (en)
Inventor
Stewart Cole
Roland Brosch
Stephen Glyn Hewinson Gordon
Karin Eiglmeier
Thierry Garnier
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE360097T1 publication Critical patent/ATE360097T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/5695Mycobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
AT02290458T 2002-02-25 2002-02-25 Spezifisch vom genom von mycobacterium tuberculosis deletierte sequenzen und deren verwendung in der diagnostik und als vakzine ATE360097T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02290458A EP1338657B9 (de) 2002-02-25 2002-02-25 Spezifisch vom Genom von Mycobacterium tuberculosis deletierte Sequenzen und deren Verwendung in der Diagnostik und als Vakzine

Publications (1)

Publication Number Publication Date
ATE360097T1 true ATE360097T1 (de) 2007-05-15

Family

ID=27635905

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02290458T ATE360097T1 (de) 2002-02-25 2002-02-25 Spezifisch vom genom von mycobacterium tuberculosis deletierte sequenzen und deren verwendung in der diagnostik und als vakzine
AT03706832T ATE403752T1 (de) 2002-02-25 2003-02-25 Genetischer marker zur differenzierung von mycobakterien

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03706832T ATE403752T1 (de) 2002-02-25 2003-02-25 Genetischer marker zur differenzierung von mycobakterien

Country Status (12)

Country Link
US (1) US7977047B2 (de)
EP (2) EP1338657B9 (de)
JP (1) JP4738740B2 (de)
AT (2) ATE360097T1 (de)
AU (1) AU2003208539B2 (de)
CA (1) CA2477195C (de)
CY (1) CY1106584T1 (de)
DE (2) DE60219589T2 (de)
DK (1) DK1338657T3 (de)
ES (1) ES2286212T3 (de)
PT (1) PT1338657E (de)
WO (1) WO2003070981A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1350839B1 (de) 2002-04-05 2010-06-02 Institut Pasteur Identifizierung der Virulenz-assoziierten Regionen RD1 und RD5, die die Entwicklung von verbesserten Impfstoffen mit M. bovis BCG und M. microti ermöglicht
US20050164168A1 (en) * 2003-03-28 2005-07-28 Cullum Malford E. Method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
GB0406271D0 (en) * 2004-03-19 2004-04-21 Isis Innovation Diagnostic test
CN102329880B (zh) * 2004-04-26 2014-05-14 和光纯药工业株式会社 结核菌检测用的引物和探针以及使用它们检测人型结核菌的方法
EP1922415B1 (de) * 2005-09-05 2013-12-25 Bio-Rad Innovations Verwendung von sowohl rd9 als auch is6110 als nukleinsäureziele für die diagnose von tuberkulose und bereitstellung multiplex-tauglicher is6110- und rd-9-ziele
BRPI0604958B1 (pt) * 2006-11-23 2022-05-17 Fundação Oswaldo Cruz Kit para distinção de mycobacterium tuberculosis, m. bovis, m. bovis bcg em uma amostra, e, método para distinguir mycobacterium tuberculosis, m. bovis, m. bovis bcg
WO2010132112A2 (en) 2009-05-14 2010-11-18 Wisconsin Alumni Research Foundation Immunogenic compositions against tuberculosis
KR101498705B1 (ko) * 2010-07-02 2015-03-06 (주)바이오니아 결핵 진단용 프라이머, 프로브, 이를 포함하는 키트 및 상기 키트를 이용한 결핵 진단 방법
JP2013055947A (ja) * 2012-10-26 2013-03-28 Bio-Rad Innovations 結核の診断のための核酸標的としてのrd9およびis6110の使用、ならびにマルチプレックス−コンプライアントis6110およびrd9標的の提供
ES2864855T3 (es) * 2014-07-24 2021-10-14 Abbott Molecular Inc Métodos para la detección y análisis de mycobacterium tuberculosis
US10677797B2 (en) 2016-03-11 2020-06-09 S&R Pharmaceuticals, Llc Assays and methods for detecting mycobacterial infections
CN106868113A (zh) * 2017-01-24 2017-06-20 中国疾病预防控制中心传染病预防控制所 用于鉴定牛型结核分枝杆菌的snp标记及其应用
WO2022235518A1 (en) * 2021-05-03 2022-11-10 The Board Of Trustees Of The Leland Stanford Junior University Method for diagnosing active tuberculosis and progression to active tuberculosis
KR20220164261A (ko) 2021-06-04 2022-12-13 (주)아모레퍼시픽 단백질 분해효소 안정성 증진용 조성물, 이를 포함하는 동결건조 조성물, 이를 포함하는 화장품 키트, 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
US6291190B1 (en) * 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex
FR2791067B1 (fr) * 1999-03-16 2003-01-31 Pasteur Institut Sequence deletees chez m.bovis bcg/m.ou m.tuberculosis, procede de detection des mycobacteries utilisant ces sequences et vaccins
WO2001002555A1 (en) * 1999-07-06 2001-01-11 Institut Pasteur Method of making and identifying attenuated microorganisms, compositions utilizing the sequences responsible for attenuation, and preparations containing attenuated microorganisms

Also Published As

Publication number Publication date
PT1338657E (pt) 2007-06-21
US20060127897A1 (en) 2006-06-15
AU2003208539B2 (en) 2008-11-20
US7977047B2 (en) 2011-07-12
WO2003070981A2 (en) 2003-08-28
WO2003070981A3 (en) 2003-12-04
AU2003208539A1 (en) 2003-09-09
CY1106584T1 (el) 2012-01-25
WO2003070981A8 (en) 2004-10-07
EP1338657A1 (de) 2003-08-27
ES2286212T3 (es) 2007-12-01
DE60322674D1 (de) 2008-09-18
JP4738740B2 (ja) 2011-08-03
DK1338657T3 (da) 2007-07-30
EP1338657B1 (de) 2007-04-18
EP1478777B1 (de) 2008-08-06
CA2477195C (en) 2015-01-06
DE60219589D1 (de) 2007-05-31
DE60219589T2 (de) 2008-02-14
EP1338657B9 (de) 2007-10-10
JP2005518203A (ja) 2005-06-23
EP1478777A2 (de) 2004-11-24
CA2477195A1 (en) 2003-08-28
ATE403752T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
ATE360097T1 (de) Spezifisch vom genom von mycobacterium tuberculosis deletierte sequenzen und deren verwendung in der diagnostik und als vakzine
Gagneux Genetic diversity in Mycobacterium tuberculosis
ATE534749T1 (de) Sonde und primer zum nachweis von tuberkelbazillen sowie verfahren zum nachweis von tuberkelbazillen beim menschen damit
ATE430812T1 (de) Materialien und verfahren zum einfangen von krankheitserregern und zur abtrennung von aurintricarbonsäure aus einer probe
MY182940A (en) Pcr primer set for bacterial dna amplification, kit for detecting and/or identifying bacterial species, and method for detecting and/or identifying bacterial species
CY1109210T1 (el) Διαγραφεισες αλληλουχιες στο μ. bovis bcg/m. bovis ΄η μ. tuberculosis, μεθοδος ανιχνευσεως μυκοβακτηριων που χρησιμοποιουν αυτες τις αλληλουχιες και εμβολια
DE60143314D1 (de) Estimmung der präsenz von cryptosporidium organismen in einer testprobe
ATE522608T1 (de) Primer und sonde zum nachweis von mycobacterium avium sowie verfahren zum nachweis von mycobacterium avium unter verwendung des primers bzw. der sonde
MY144277A (en) Methods for detection of mycobacterium tuberculosis
DE602004026893D1 (de) Rung und zum nachweis von mikroorganismen
ATE548465T1 (de) Diagnoseverfahren und dafür geeignete produkte
JP2017521086A5 (de)
KR20190022871A (ko) 퀀타매트릭스 어세이 플랫폼 기반 결핵 및 비결핵 항산균의 검출 및 퀀타매트릭스 어세이 플랫폼 기반 결핵 및 비결핵 항산균의 검출 및 동정과 결핵균의 리팜핀 내성여부를 동시 확인할 수 있는 진단법 및 그 키트
Amoudy et al. Identification of transcriptionally active open reading frames within the RD1 genomic segment of Mycobacterium tuberculosis
Quan et al. Development of one-tube multiplex polymerase chain reaction (PCR) for detecting Mycobacterium bovis
ATE430209T1 (de) Nachweis, identifizierung und differenzierung von eubakterien unter verwendung eines hybridisierungs-assays
Slany A new cultivation‐independent tool for fast and reliable detection of M ycobacterium marinum
DE602006008263D1 (de) Verfahren zur Detektion von Staphylococcus epidermidis
ATE518964T1 (de) Verfahren und kit zum spezifischen nachweis von m. tuberculosis
DE602006017757D1 (de) Verfahren zum Nachweis von Bakterien der Gattung Mycobacterium (säureresistente Bakterien)
Chaiprasert et al. One-tube multiplex PCR method for rapid identification of Mycobacterium tuberculosis
ATE520790T1 (de) Nachweis, identifizierung und differenzierung von eubakterien unter verwendung eines hybridisierungs-assays
DE602005017279D1 (de) Verfahren zur überwachung genomischer dna von organismen
ATE307906T1 (de) Verfahren zum nachweis von gram-positiven bakterien
EP1044282A1 (de) Eine methode zur diagnose, identifizierung und charakterisierung von m. tuberculosis und anderer mycobakterien durch einen mobilitäts shift assay

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1338657

Country of ref document: EP